MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
23:04
Dinamo Bucharest defeated SCM Poli Timișoara 35-25 in the first semifinal of the Romanian Supercup, marking the debut of the new season.
23:01
Rapid Bucharest defeated Petrolul Ploiești 2-0 in the first match of the sixth round of the Super League
22:53
Dominic Fritz comments on the CCR's reasoning: "We can rest easy. The sanction does not apply to me, but to my mandate."
22:45
The U.S. Supreme Court temporarily authorized the continuation of work on the White House ballroom, suspending a court order that would have halted the project.
22:24
"We have a set of measures prepared" against Russia, announces Oana Ţoiu. Romania is ready to respond diplomatically and militarily.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
